Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-752P refers to a pseudogene of the U6 small nuclear RNA (snRNA) family, specifically the 752nd annotated locus. Pseudogenes are DNA sequences similar to functional genes but are typically non-functional due to accumulated mutations or lack of necessary regulatory elements[2][5]. The U6 snRNA, when functional, plays a critical role in the spliceosome, the molecular machine responsible for pre-mRNA splicing in eukaryotic cells[1][3]. However, as a pseudogene, RNU6-752P does not encode a functional RNA or protein and is not involved in the splicing reaction or any active cellular biochemical process. There is also no evidence that this particular pseudogene has a direct role in disease, functions as a biomarker, interacts with drugs, or is a therapeutic target. Its classification is strictly as a pseudogene, not a receptor, enzyme, or conventional drug target. Thus, it is not considered a biological therapeutic target, and there are no known mechanisms of action, disease roles, or safety concerns related to this locus[2][5].\n\nNotes: \n- No evidence that RNU6-752P is misspelled; the name is correct but the entity is not a functional or druggable target.\n- Pseudogenes can sometimes regulate gene expression via RNA-based mechanisms in specific cases, but there is no current evidence for such a function for RNU6-752P specifically[4]. \n- It is not a canonical therapeutic target such as a receptor, transporter, or enzyme but is part of genome annotation due to sequence similarity to functional U6 snRNA genes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 752, pseudogene (RNU6-752P).